Peck Ronald 4
4 · ARVINAS, INC. · Filed Feb 27, 2024
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Peck Ronald
Chief Medical Officer
Transactions
- Award
Common Stock
2024-02-23+39,250→ 69,215 total - Sale
Common Stock
2024-02-23$47.05/sh−1,699$79,938→ 67,516 total - Award
Stock Option (right to buy)
2024-02-23+58,100→ 58,100 totalExercise: $47.00Exp: 2034-02-22→ Common Stock (58,100 underlying)
Footnotes (3)
- [F1]The restricted stock units (each, an "RSU") were granted by the Issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.
- [F2]This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
- [F3]The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.